Related Experiment Video

Updated: Jun 27, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.5K

Social and Structural Determinants of Cardiovascular Complications of Diabetes

Portia Mensah1,2, Kelly Valdez1,2, Ankita Gyawali1

  • 1Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Mail Stop F547, Aurora, CO, 80045, USA.

Current Diabetes Reports
|May 2, 2024
PubMed

Insights

Racial and ethnic minorities with diabetes face higher cardiovascular disease mortality due to social and structural determinants of health. Addressing these inequities is crucial for improving health outcomes.

Area of Science:

  • Cardiovascular Health
  • Diabetes Management
  • Health Equity

Background:

  • Cardiovascular disease (CVD) is the primary cause of death for individuals with diabetes.
  • Racial and ethnic minorities with diabetes often experience poorer management of cardiovascular risk factors, leading to increased mortality.
  • Social and structural determinants of health significantly impact an individual's capacity for adopting healthy behaviors.

Purpose of the Study:

  • To review cardiovascular complications in people with diabetes.
  • To examine the relationship between these complications and social determinants of health (SDOH).

Main Methods:

  • Literature review of cardiovascular complications in diabetic populations.
  • Analysis of the impact of social and structural determinants on cardiovascular health in diabetes.

Main Results:

  • Despite advancements in diabetes care, disparities persist in treatment accessibility for racial and ethnic minorities.
  • These inequities in access contribute to ongoing disparities in cardiovascular disease outcomes.
  • Racial/ethnic disparities in CVD are linked to systemic issues including economic opportunity, education, health literacy, neighborhood conditions, and healthcare access, all influenced by structural racism.

Conclusions:

  • Social and structural determinants of health are critical factors influencing cardiovascular outcomes in people with diabetes.
  • Addressing systemic inequities is essential to reduce cardiovascular disease mortality among minority populations with diabetes.
Abstract

Keywords:
Cardiovascular DiseaseDiabetesDisparitiesSocial Determinants of HealthStructural Determinants of HealthType 1 diabetesType 2 diabetes

More Related Videos

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

861
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

583

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
922
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
526
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K